Suárez MR, Carrasco VH, Elorriaga SS, Millán CS, Gutiérrez GZ

Language: Spanish
References: 27
Page: 108-113
PDF size: 111.98 Kb.

ABSTRACT

Parkinson disease (PD) is a motor syndrome that is associated with dopamine deficiency to degenerate the subcortical nucleus that produces it. While demonstrations are almost exclusively motor, research in recent decades have shown that cognitive disorders are part of the clinical symptoms of PD, there are many gaps that occur in this disease, which include impaired attention, orientation, the executive system deficits, impaired visuospatial processing and language by which neuropsychological evaluation was performed using the Barcelona test in PD patients and the results were correlated with the levels obtained by SPECT perfusion brain.

REFERENCES

1. Masdeu J, Arvizu J, Toledo J, Valero M. SPECT y PET en neurología. Rev de Neurol 2006; 5: 219-25.

2. Fustinoni J. Neurología en esquemas. 2a. Ed. Buenos Aires: El Ateneo; 1997, p. 136-203.

3. Rains D. Principios de neuropsicología humana. 1a. Ed. México, D.F.: McGrawHill; 2002, p. 117-203.

4. Haines DE. Principios de neurociencia. 2a. Ed. España, Madrid: Elsevier; 2003, p. 405-22.

5. Kandel E, Schwartz J, Jessell T. Principios de neurociencia, 4a. Ed. Madrid: McGraw-Hill; 2000, p. 653-74.

6. Cuevas C. Diagnóstico de la enfermedad de Parkinson idiopática. México, D.F.: PyDesa; 2008, p. 18-49.

7. Koller W. How accurately can Parkinson’s disease be diagnosed? Neurology 1992; 42: 6-16.

8. Tröster A. Assesment of movement and demyelinating. Clinical Neuropsychology 2002; 3: 72-97.

9. Catafu A. Brain SPECT in clinical practice. J Nucl Med 2001; 42(2): 259-71.

10. Devous M. Single-photon emission computed tomography in neurotherapeutics. NeuroRx 2005; 2(2): 237-49.

11. Lassen N, Holms S. Single Photon Emission Computerized Tomography (SPECT). 4a. Ed. Estados Unidos, New York: Oxford University Press; 1992, p. 1102-40.

12. Parellada E. Introducción a las aplicaciones del SPECT cerebral en psiquiatría. Rev Psiquiatría Fac Med Barna 2001; 28(1): 16-21.

13. Valle M, García F. SPECT Cerebral. Revista Peruana de Radiología 1999; 3: 23-34.

14. Behrens C. Medicina nuclear. España, Barcelona: Salvat; 1986, p. 71-156.

15. Berko J, Berstein N. Psicolingüistica. España, Madrid: McGrawHill; 2009, p. 78-113.

16. Poldrack R, Wagner A, Prull M, Desmond J, Glover G, Gabrieli J. Functional specialization for semantic and phonological processing in the left inferior prefrontal cortex. Neuroimage 1991; 10: 15-35.

17. Levelt W, Roelofs A, Meyer A: A theory of lexical access in speech production. Behav Brain Sci 1999; 22: 1-75.

18. Rayner K, Pollatsek A. Handbook of psychology: experimental psychology, Estados Unidos: Oxford, Elsevier; 2003, p. 25-172.

19. González B. Diagnóstico de la enfermedad de Parkinson idiopática. México, D.F.: PyDesa; 2008, p. 18-49.

20. Perea-Bartolomé M. Deterioro cognitivo en la enfermedad de Parkinson. Rev de Neurol 2001; 32(12): 1182-7.

21. Lezak M: Neuropsychological assessment. 3a. Ed. Estados Unidos, New York: Oxford University Press; 1983, p. 230-402.

22. Damasio A, Damasio H, Rizzo M, Varney N, Gersh F: Aphasia with nonhemorrhagic lesions in the basal ganglia and internal capsule. Arch Neurol 1982; 39(1): 15-20.

23. Darkins A. Fromkin V, Benson D. A characterization of the prosodic loss in Parkinson’s disease. Estados Unidos: Oxford: Elsevier; 1998, p. 34-100.

24. Junqué C, Bruna O, Mataró M. Neuropsicología del lenguaje. Funcionamiento normal y patológico. 3a. Ed. España, Madrid: Elsevier; 2004, p. 450-79.

25. Nadeau S. Phonologic aspects of language disorders. 2a. Ed. Estados Unidos: Oxford Elsevier; 2003, p. 87-145.

26. Pickett E. Selective speech motor syntax and cognitive deficits associated with bilateral damage to the putamen and the head of the caudate nucleus. Neuropsychology 1998; 36(1): 23-39.

27. Norma Oficial Mexicana nom-168-ssa1-1998, del expediente clínico.